Evidence map›Paper›PMID 25192252›Full record

ArticlePloS one2014

Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia.

Jonathan L Slaughter, Michael R Stenger, Patricia B Reagan, Sudarshan R Jadcherla

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Inhaled hydrofluoalkane-beclomethasone dipropionate in bronchopulmonary dysplasia. A double-blind, randomized, controlled pilot study.Journal of perinatology : official journal of the California Perinatal Association · 2017
    Trial
  5. Trial
  6. Article
  7. Prescribing practices of inhaled corticosteroids for premature infants in the neonatal intensive care unit.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Inhaled Pharmacotherapy for Neonates: A Narrative Review.Turkish archives of pediatrics · 2022
    Article
  13. Low-dose hyperoxia primes airways for fibrosis in mice after influenza A infection.American journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  14. Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia.Journal of perinatology : official journal of the California Perinatal Association · 2021
    Review
  15. Cost of clinician-driven tests and treatments in very low birth weight and/or very preterm infants.Journal of perinatology : official journal of the California Perinatal Association · 2021
    Article
  16. Observational
  17. [Research progress in drug therapy for bronchopulmonary dysplasia in preterm infants].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2018
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jonathan L SlaughterThe Department of Pediatrics, The Ohio State University College of Medicine and Nationwide Children's Hospital, Columbus, Ohio, United States of America; Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America.
Michael R StengerThe Department of Pediatrics, The Ohio State University College of Medicine and Nationwide Children's Hospital, Columbus, Ohio, United States of America; Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America.
Patricia B ReaganCenter for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America; The Department of Economics, The Ohio State University, Columbus, Ohio, United States of America; Center for Human Resource Research, The Ohio State University, Columbus, Ohio, United States of America.
Sudarshan R JadcherlaThe Department of Pediatrics, The Ohio State University College of Medicine and Nationwide Children's Hospital, Columbus, Ohio, United States of America; Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America; The Neonatal and Infant Feeding Disorders Research Program, Nationwide Children's Hospital, Columbus, Ohio, United States of America.
The Ohio State University · US

Funding

Comparative Effectiveness of N-said Treatment Versus No Treatment for PDA in PretK08HL121182 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI SLAUGHTER, JONATHAN LEE · 2014 to 2017
$551k
NHLBI NIH HHS K08 HL121182NHLBI NIH HHS K08HL121182
6 · The paper itself

Abstract

objectiveTo determine demographic and clinical variables associated with inhaled corticosteroid administration and to evaluate between-hospital variation in inhaled steroid use for infants with bronchopulmonary dysplasia (BPD).

designRetrospective Cohort Study.

settingNeonatal units of 35 US children's hospitals; as recorded in the Pediatric Health Information System (PHIS) database. PATIENTS: 1429 infants with evolving BPD at 28 days who were born at <29 weeks gestation with birth weight <1500 grams, admitted within the first 7 postnatal days, and discharged between January 2007-June 2011.

resultsInhaled steroids were prescribed to 25% (n = 352) of the cohort with use steadily increasing during the first two months of hospitalization. The most frequently prescribed steroid was beclomethasone (n = 194, 14%), followed by budesonide (n = 125, 9%), and then fluticasone (n = 90, 6%). Birth gestation <24 weeks, birth weight 500-999 grams, and prolonged ventilation all increased the adjusted odds of ever receiving inhaled corticosteroids (p<0.05). Wide variations between hospitals in the frequency of infants ever receiving inhaled steroids (range: 0-60%) and the specific drug prescribed were noted. This variation persisted, even after controlling for observed confounders.

conclusionsInhaled corticosteroid administration to infants with BPD is common in neonatal units within U.S. Children's hospitals. However, its utilization varies markedly between centers from no treatment at some institutions to the majority of infants with BPD being treated at others. This supports the need for further research to identify the benefits and potential risks of inhaled steroid usage in infants with BPD.

Indexed as

Administration, InhalationBeclomethasoneBronchopulmonary DysplasiaBudesonideFluticasoneGlucocorticoidsHumansInfantInfant, Low Birth WeightInfant, NewbornInpatientsRetrospective StudiesBeclomethasoneBudesonideFluticasoneGlucocorticoids

Identifiers

PMID25192252
PMCPMC4156388
OpenAlexW1988676681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.